Malignant tumours after transplantation of thoracic organs;Malignome nach thorakaler organtransplantation

Deutsche Medizinische Wochenschrift

Volumn 123, Issue 1-2, 1998, Pages 26-29

  Stempfle, H U ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PREVENTION; CANCER SCREENING; GERMANY; HEART LUNG TRANSPLANTATION; HUMAN; LUNG CANCER; LYMPHOMA; METASTASIS; ORGAN TRANSPLANTATION; REVIEW;

EID: 0032472355     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1023894     Document Type: Review

References (31)

1. Barr, B. B. B., E. C. Benton, K. McLaren et al.: Human papilloma virus infection and skin cancer in renal allograft recipients. Lancet i (1989), 124-129.
2. Bernstein, D., D. Baum, G. Berry, G. Dahl, L. Weiss, V. A. Starnes, P. Gamberg, E. B. Stinson: Neoplastic disorders after pediatric heart transplantation. Circulation 88 (1993), 230-237.
3. Calne, R. Y.: Cyclosporine in cadaveric renal transplantation. 5-year follow-up of a multicentre trial. Lancet ii (1987), 506-507.
4. Chen, J. M., M. L. Barr, A. Chadburn, G. Frizzera, F. A. Schenkel, R. R. Sciacca, D. S. Reison, L. J. Addonizio, E. A. Rose, D. M. Knowles, R. E. Michler: Management of lymphoproliferative disorders after cardiac transplantation. Ann. thorac. Surg. 56 (1993), 527-538.
5. Cleary, M. L., M. A. Nalesnik, W. T. Shearer, J. Sklar: Monoclonality of lymphoproliferative lesions in cardiac-transplant recipients. New Engl. J. Med. 310 (1984), 477-482.
6. Couetil, J. P., J. P. McGoldrick et al.: Malignant tumors after heart transplantation. J. Heart Transplant. 6 (1990), 622-626.
7. Eurvard, S., M. Verschoore, J. L. Touraine et al.: Topical retinoids for warts and keratoses in transplant recipients. Lancet 340 (1992), 48.
8. van Gorp, J., H. Doornewaard, L. F. Verdonck et al.: Posttransplant T-cell lymphoma. Cancer 73 (1994), 3064-3072.
9. Greene, M. H., T. I. Young, W. H. Clark Jr.: Malignant melanoma in renal-transplant recipients. Lancet i (1981), 1196-1199.
10. Hartevelt, A. R. J. N. Bouwes-Bavinck, A. M. Koote, B. J. Vermeer, J. P. Vandenbroucke: Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation 49 (1990), 506-509.
11. Hosenpud, J., R. J. Novick, L. E. Bennett, B. M. Keck, B. Fiol, O. P. Daily: The registry of the international society for heart and lung transplantation. J. Heart Lung Transplant. 15 (1996), 655-674.
12. Knowles, D. M., E. Cesarman, A. Chadburn et al.: Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood 85 (1995), 552-565.
13. Krikorian, J. G., J. L. Anderson, C. P. Bieber: Malignant neoplasms following cardiac transplantation. J. Amer. Med. Ass. 240 (1978), 639-643.
14. Lanza, R. P., D. K. C. Cooper, M. J. D. Cassidy, C. N. Barnard: Malignant neoplasms occurring after cardiac transplantation. J. Amer. Med. Ass. 249 (1983), 1746-1748.
15. Lennard, L., S. Thomas, C. Harrington, J. L. Maddocks: Skin cancer in renal transplant recipients is associated with increased concentrations of 6-thioguanine nucleotide in red blood cells. Brit. J. Dermatol. 113 (1985), 723-729.
16. Morrison, V. A., D. L. Dunn, J. C. Manivel, K. J. Gajl-Peczalska, B. A. Peterson: Clinical characteristics of post-transplant lymphoproliferative disorders. Amer. J. Med. 97 (1994), 14-24.
17. Nalesnik, M. A., L. Makowka, T. E. Starzl: The diagnosis and treatment of posttransplant lymphoproliferative disorders. Curr. Probl. Surg. 25 (1988), 371-472.
18. Oda, D., R. Persson, G. Haigh, D. E. Sabath, I. Penn, S. Aziz: Oral presentation of posttransplantation lymphoproliferative disorders. Transplantation 61 (1996), 435-440.
19. Opelz, G., R. Henderson: Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 342 (1993), 1514.
20. Penn, I., G. Porat: Central nervous system lymphomas in organ allograft recipients. Transplantation 59 (1995), 240-244.
21. Penn, I.: Malignant neoplasia in the immunocompromised patient. In Cooper, D. K. C., L. W. Miller: The transplantation and replacement of thoracic organs (Kluwer Academic Publishers: London 1996), 111-117.
22. Penn, I.: The changing patterns of posttransplant malignancies. Transplant. Proc. 23 (1991), 1101-1103.
23. Penn, I.: Cancers complicating organ transplantation. ASHI Report (1997), 6-8.
24. Penn, I.: Incidence and treatment of neoplasia after transplantation. J. Heart Lung Transplant. 12 (1993), 328-336.
25. Penn, I.: Malignant melanoma in organ allograft recipients. Transplantation 61 (1996), 274-278.
26. Porreco, R., I. Penn, W. Droegemueller, B. Greer, E. Makowski: Gynecologic malignancies in immunosuppressed organ homograft recipients. Obstet. Gynecol. 45 (1975), 359-364.
27. Schröter, G. P. J., R. Weil III, I. Penn, W. C. Speers, W. R. Waddell: Hepatocellular carcinoma associated with chronic hepatitis B virus infection after kidney transplantation (Letter). Lancet 1982/11, 381-382.
28. Sillmann, F., A. Stanek et al.: The relationship between human papillomavirus and lower genital intraepithelial neoplasia in immunosuppressed woman. Amer. J. Obstet. Gynecol. 480 (1995), 300-308.
29. Stempfle, H. U., H. Mudra, C. E. Angermann et al.: Rapid growth of cutaneous neuroendocrine (Merkel cell) carcinoma during treatment of refractory cardiac allograft rejection with OKT3 monoclonal antibody. J. Heart Lung Transplant. 12 (1993), 501-503.
30. Swinnen, L. J., M. R. Costanzo-Nordin et al.: Increased incidence of lymphoproliferative disorders after immunosuppression with monoclonal antibody OKT3 in cardiac transplant recipients. New Engl. J. Med. 323 (1990), 1723-1728.
31. Wagner, D., I. Wagenbreth et al.: Failure of vaccination against hepatitis B with Gen H-B-Vax-D in immunosuppresses heart transplant recipients. Clin. Invest. 70 (1992), 585-587.